Concepedia

Analysis of the changes induced by bevacizumab using a high temporal resolution DCE-MRI as prognostic factors for response to further neoadjuvant chemotherapy

J. Etxano, Luís Pina Insausti, Arlette Elizalde, José Manuel López Vega, Arrate Plazaola

Acta Radiologica · 2014 · 13 citations · 19 references

DOI

Abstract

Bevacizumab induces remarkable tumoral volume, pharmacodynamics, and pharmacokinetic changes. However, these changes could not be used as early predictors for response to further neoadjuvant therapy.

References

19

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

Kathy D. Miller, Molin Wang, Julie R. Gralow et al. · New England Journal of Medicine · 2007 · 3K citations · Full text

A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival

Keith N. Ogston, Iain D. Miller, Simon Payne et al. · The Breast · 2003 · 969 citations · Full text

, , +17

Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer

Suparna Wedam, Jennifer A. Low, Sherry X. Yang et al. · Journal of Clinical Oncology · 2006 · 521 citations · Full text

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer

Harry D. Bear, Gong Tang, Priya Rastogi et al. · New England Journal of Medicine · 2012 · 464 citations · Full text

Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model

Paul S. Tofts, Bruce A. Berkowitz, Mitchell D. Schnall · Magnetic Resonance in Medicine · 1995 · 403 citations